Fidelity Disruptive Medicine ETF Company Overview
Fidelity Disruptive Medicine ETF
About Fidelity Disruptive Medicine ETF
Fidelity Disruptive Medicine ETF (NASDAQ:FMED) focuses on healthcare innovation, investing in companies that redefine or accelerate the medical industry through technology and groundbreaking approaches. This ETF targets firms across various stages of product development, from initial research to commercialization, emphasizing areas like biotechnology, pharmaceuticals, life sciences, and healthcare equipment. Fidelity Disruptive Medicine ETF aims to provide investors with exposure to potentially high-growth opportunities within the disruptive healthcare sector, demonstrating a commitment to capturing the value generated by innovative medical solutions and advancements.
What is Fidelity Disruptive Medicine ETF known for?
Snapshot
2020
Year founded
75996
Employees
Boston, United States
Head office
Loading Map...
Operations
All Locations
United States
Produtos e/ou serviços de Fidelity Disruptive Medicine ETF
- Focused investment in innovative healthcare companies.
- Explores advancements in genomics and biotechnology.
- Captures transformation in digital health and telemedicine services.
- Invests in breakthrough medical devices.
- Targets companies revolutionizing patient diagnostics.
- Supports firms developing personalized and precision medicine.